GeneDx Holdings Price to Book Ratio 2020-2024 | WGS
Historical price to book ratio values for GeneDx Holdings (WGS) over the last 10 years. The current price to book ratio for GeneDx Holdings as of February 18, 2025 is 10.26.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| GeneDx Holdings Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-02-14 | 76.35 | 10.24 | |
| 2024-09-30 | 42.44 | $7.45 | 5.69 |
| 2024-06-30 | 26.14 | $7.21 | 3.63 |
| 2024-03-31 | 9.13 | $7.93 | 1.15 |
| 2023-12-31 | 2.75 | $8.78 | 0.31 |
| 2023-09-30 | 3.64 | $9.83 | 0.37 |
| 2023-06-30 | 5.96 | $11.49 | 0.52 |
| 2023-03-31 | 0.37 | $13.58 | 0.03 |
| 2022-12-31 | 0.26 | $21.55 | 0.01 |
| 2022-09-30 | 0.88 | $48.57 | 0.02 |
| 2022-06-30 | 1.26 | $55.36 | 0.02 |
| 2022-03-31 | 3.07 | $44.35 | 0.07 |
| 2021-12-31 | 4.46 | $52.79 | 0.08 |
| 2021-09-30 | 7.59 | $53.76 | 0.14 |
| 2021-06-30 | 14.01 | $6.72 | 2.09 |
| 2021-03-31 | 14.89 | $6.38 | 2.33 |
| 2020-12-31 | 10.35 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.097B | $0.203B |
| GeneDx Holdings Corp. is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by rare disease data sets. GeneDx Holdings Corp., formerly known as Sema4 Holdings Corp., is based in STAMFORD, Conn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.005B | 27.54 |
| Elevance Health (ELV) | United States | $90.276B | 11.81 |
| CVS Health (CVS) | United States | $82.998B | 12.15 |
| Cencora (COR) | United States | $47.050B | 17.08 |
| DiDi Global (DIDIY) | China | $24.788B | 0.00 |
| Natera (NTRA) | United States | $22.891B | 0.00 |
| ICON (ICLR) | Ireland | $15.361B | 13.68 |
| Doximity (DOCS) | United States | $14.388B | 74.82 |
| BioMerieux (BMXMF) | France | $13.819B | 0.00 |
| Revvity (RVTY) | United States | $13.662B | 22.91 |
| Viatris (VTRS) | United States | $12.891B | 3.97 |
| Solventum (SOLV) | United States | $12.825B | 0.00 |
| Avantor (AVTR) | United States | $12.168B | 17.87 |
| CochLear (CHEOY) | Australia | $11.076B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.364B | 26.93 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.228B | 0.00 |
| HealthEquity (HQY) | United States | $9.766B | 49.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.787B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.772B | 15.02 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.784B | 26.90 |
| Organon (OGN) | United States | $3.935B | 4.01 |
| BrightSpring Health Services (BTSG) | United States | $3.839B | 81.67 |
| Sotera Health (SHC) | United States | $3.818B | 20.42 |
| Surgery Partners (SGRY) | United States | $3.288B | 37.49 |
| Concentras Parent (CON) | United States | $2.893B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.622B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.467B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.108B | 0.00 |
| PACS (PACS) | United States | $2.041B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.921B | 50.40 |
| Progyny (PGNY) | United States | $1.904B | 38.55 |
| Premier (PINC) | United States | $1.623B | 10.39 |
| Agilon Health (AGL) | United States | $1.409B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.314B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.207B | 11.81 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.892B | 6.04 |
| Embecta (EMBC) | United States | $0.863B | 5.92 |
| Auna S.A (AUNA) | Luxembourg | $0.639B | 0.00 |
| DocGo (DCGO) | United States | $0.565B | 21.31 |
| SBC Medicals (SBC) | United States | $0.492B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.486B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.458B | 0.00 |
| MultiPlan (MPLN) | United States | $0.446B | 0.00 |
| Enhabit (EHAB) | United States | $0.437B | 37.83 |
| QDM (QDMI) | Hong Kong, SAR China | $0.421B | 11.03 |
| Nutex Health (NUTX) | United States | $0.359B | 0.00 |
| LifeMD (LFMD) | United States | $0.332B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.313B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.181B | 0.00 |
| Biodesix (BDSX) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.136B | 0.00 |
| So-Young (SY) | China | $0.112B | 19.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| ModivCare (MODV) | United States | $0.084B | 4.57 |
| IceCure Medical (ICCM) | Israel | $0.075B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.017B | 0.00 |
| KindlyMD (KDLY) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |